It's usually not a very good sign when PPT start selling, however it seems as though it's only UBS out at the moment.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025